Live from the NIH registry
Studies recruiting near Huntsville right now
Top 25 of 95 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Huntsville, AL Investigative Site 10026 — Huntsville, Alabama (3.9 mi)
· Sponsor: Colorado Prevention Center
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Heart Center Rsrch_Hunstville — Huntsville, Alabama (3.9 mi)
· Sponsor: Novo Nordisk A/S
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Huntsville, Alabama (3.9 mi)
· Sponsor: TG Therapeutics, Inc.
A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
Alzheimer Disease
N/A
Observational 6,250 participants sought
Rehabilitation & Neurological Services — Huntsville, Alabama (3.9 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Obesity or Overweight
Phase 3
Interventional 2,500 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: AstraZeneca
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
Normal and Diseased Tissue and Body Fluids Samples
N/A
Observational 100,000 participants sought
St. Jude Clinic at Huntsville Hospital for Women & Children — Huntsville, Alabama (3.9 mi)
· Sponsor: St. Jude Children's Research Hospital
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: AstraZeneca
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: DalCor Pharmaceuticals
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile, Clostridium Difficile Infections
Phase 3
Interventional 852 participants sought
Metro Infectious Disease Consultants — Huntsville, Alabama (3.9 mi)
· Sponsor: Vedanta Biosciences, Inc.
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Chronic Kidney Disease
Phase 3
Interventional 7,000 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: AstraZeneca
A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices
Vascular Access Device
N/A
Observational 2,500 participants sought
Huntsville Hospital — Huntsville, Alabama (3.9 mi)
· Sponsor: Teleflex
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
Oropharyngeal Carcinoma (OPC)
Phase 3
Interventional 260 participants sought
Clearview Cancer Institute — Huntsville, Alabama (3.9 mi)
· Sponsor: Corbus Pharmaceuticals Inc.
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
Phase 3
Interventional 1,059 participants sought
Rehabilitation & Neurological Services /ID# 229969 — Huntsville, Alabama (3.9 mi)
· Sponsor: AbbVie
MicroRNA Correlates of Childhood Maltreatment and Suicidality
Major Depressive Disorder, Suicidal Ideation
N/A
Observational 450 participants sought
UAB Huntsville Regional Medical Campus — Huntsville, Alabama (3.9 mi)
· Sponsor: University of Alabama at Birmingham
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
Bipolar I Disorder, Bipolar II Disorder
Phase 2
Interventional 195 participants sought
University of Alabama - Huntsville Regional Medical Campus /ID# 272951 — Huntsville, Alabama (3.9 mi)
· Sponsor: AbbVie
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Renal Insufficiency, Chronic
Phase 3
Interventional 2,800 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: AstraZeneca
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
Waldenstrom Macroglobulinemia
N/A
Observational 111 participants sought
Clearview Cancer Institute — Huntsville, Alabama (3.9 mi)
· Sponsor: BeiGene
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
Heart Failure, Congestive
Phase 4
Interventional 80 participants sought
Heart Center Research, LLC — Huntsville, Alabama (3.9 mi)
· Sponsor: Heart Center Research, LLC
Prevail Global Study
Coronary Artery Disease
N/A
Interventional 1,205 participants sought
Huntsville Hospital — Huntsville, Alabama (3.9 mi)
· Sponsor: Medtronic Vascular
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
Primary Membranous Nephropathy
Phase 3
Interventional 180 participants sought
Apogee Clinical Research, LLC — Huntsville, Alabama (3.9 mi)
· Sponsor: Biogen
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Untreated Follicular Lymphoma
Phase 3
Interventional 1,018 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: AstraZeneca
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
COVID-19 SARS-CoV-2 Infection
Phase 3
Interventional 2,330 participants sought
University of Alabama at Birmingham, Huntsville Regional Medical Campus (HRMC) — Huntsville, Alabama (3.9 mi)
· Sponsor: Pfizer
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Obesity, Overweight
Phase 3
Interventional 3,003 participants sought
AURORA-1 Clinical Site — Huntsville, Alabama (3.9 mi)
· Sponsor: Ascletis Pharma (China) Co., Limited
Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention
HIV Seropositivity
N/A
Interventional 900 participants sought
Thrive Alabama — Huntsville, Alabama (3.9 mi)
· Sponsor: University of Chicago
Aspiration Thrombectomy Using the Symphony or Prodigy System
Arterial Thromboembolism, Venous Thromboembolism
N/A
Observational 750 participants sought
Huntsville Hospital — Huntsville, Alabama (3.9 mi)
· Sponsor: Imperative Care, Inc.